ArticleAntimicrobial agents and chemotherapy2017
Coexistence of CTX-M-2, CTX-M-55, CMY-2, FosA3, and QnrB19 in Extraintestinal Pathogenic Escherichia coli from Poultry in Brazil.
Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 65 citations in OpenAlex.
- CTX-M-producingOne health (Amsterdam, Netherlands) · 2023Article
- Identification of Subunits for Novel Universal Vaccines against Three Predominant Serogroups and the Emerging O145 among Avian Pathogenic Escherichia coli by Pan-RV Pipeline.Applied and environmental microbiology · 2023Article
- Antibiotic profiling of multidrug resistant pathogens in one-day-old chicks imported from Belgium to benin.BMC veterinary research · 2023Article
- Article
- Antibiotic Susceptibility Profiles and Resistance Mechanisms to β-Lactams and Polymyxins ofMicroorganisms · 2022Article
- Fecal Shedding of Multidrug ResistantAntibiotics (Basel, Switzerland) · 2022Article
- Imported One-Day-Old Chicks as Trojan Horses for Multidrug-Resistant Priority Pathogens HarboringApplied and environmental microbiology · 2022Article
- World Health Organization critical priorityFrontiers in microbiology · 2022Article
- Prevalence of Multidrug-Resistant CTX-M Extended Spectrum Beta-Lactamase-ProducingFrontiers in veterinary science · 2022Article
- High-Frequency Detection ofFrontiers in microbiology · 2022Article
- Molecular epidemiology of cefotaxime-resistant but ceftazidime-susceptible Enterobacterales and evaluation of the in vitro bactericidal activity of ceftazidime and cefepime.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021Article
- Prevalence and Characterization of ESBL/AmpC ProducingAntibiotics (Basel, Switzerland) · 2021Article
- Clonal spread ofZoological research · 2021Article
- Molecular Characterization and Survive Abilities ofFrontiers in microbiology · 2021Article
- Escherichia coli Sequence Type 457 Is an Emerging Extended-Spectrum-β-Lactam-Resistant Lineage with Reservoirs in Wildlife and Food-Producing Animals.Antimicrobial agents and chemotherapy · 2020Article
- Detection of CMY-type beta-lactamases in Escherichia coli isolates from paediatric patients in a tertiary care hospital in Mexico.Antimicrobial resistance and infection control · 2020Article
- Article
- Antimicrobial Resistance in Farm Animals in Brazil: An Update Overview.Animals : an open access journal from MDPI · 2020Review
- Transferable Resistance to Highest Priority Critically Important Antibiotics for Human Health inFrontiers in veterinary science · 2020Article
- Genomic Features of High-Priority Salmonella enterica Serovars Circulating in the Food Production Chain, Brazil, 2000-2016.Scientific reports · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.